Who owns Adaptimmune Therapeutics?
- Ticker: ADAP
- CUSIP Number: 00653a107
Tip: Access positions for across all investors
Analyze quarterly positions in Adaptimmune Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adaptimmune Therapeutics stock
Who bought or sold Adaptimmune Therapeutics this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| EcoR1 Capital | 27M | $15M | 0% | Dec 2024 |
|
| Long Focus Capital Management | 21M | $11M | 54% | Dec 2024 |
|
| NEA Management Company | 17M | $9.2M | 0% | Dec 2024 |
|
| Two Seas Capital | 15M | $8.0M | 100% | Dec 2024 |
|
| Baillie Gifford & Co | 12M | $6.4M | -30% | Dec 2024 |
|
| MPM Asset Management | 5.6M | $3.0M | 0% | Dec 2024 |
|
| MPM Oncology Impact Management | 5.1M | $2.7M | 0% | Dec 2024 |
|
| Partner Fund Management | 4.9M | $2.6M | -51% | Dec 2024 |
|
| Bank of America Corporation | 2.9M | $1.5M | -38% | Dec 2024 |
|
| Renaissance Technologies | 2.5M | $1.4M | 53% | Dec 2024 |
|
| Rock Springs Capital Management | 2.5M | $1.3M | 2% | Dec 2024 |
|
| FMR | 1.8M | $951k | 1% | Dec 2024 |
|
| Morgan Stanley | 1.3M | $714k | -22% | Dec 2024 |
|
| Jpmorgan Chase & Co | 917k | $494k | -12% | Dec 2024 |
|
| Redmile Group | 716k | $386k | 0% | Dec 2024 |
|
| Marshall Wace | 529k | $286k | 1% | Dec 2024 |
|
| Acadian Asset Management | 510k | $269k | 100% | Dec 2024 |
|
| Rathbones Brothers | 433k | $233k | 0% | Dec 2024 |
|
| State Street Corporation | 400k | $216k | 1% | Dec 2024 |
|
| Jane Street | 327k | $176k | 88% | Dec 2024 |
|
| Citadel Advisors | 206k | $111k | 508% | Dec 2024 |
|
| BlackRock | 184k | $99k | -35% | Dec 2024 |
|
| LPL Financial | 184k | $99k | 106% | Dec 2024 |
|
| Key Client Fiduciary Advisors | 150k | $30k | -41% | Mar 2025 |
|
| UBS Group | 142k | $76k | 7701% | Dec 2024 |
|
| Geode Capital Management | 140k | $75k | 0% | Dec 2024 |
|
| Virtu Financial | 123k | $66k | 21% | Dec 2024 |
|
| Hrt Financial | 83k | $44k | 100% | Dec 2024 |
|
| Captrust Financial Advisors | 82k | $44k | -2% | Dec 2024 |
|
| Two Sigma Investments | 76k | $41k | 33% | Dec 2024 |
|
| Two Sigma Advisers | 71k | $38k | 492% | Dec 2024 |
|
| Wells Fargo & Company | 64k | $35k | -4% | Dec 2024 |
|
| Invesco | 63k | $34k | 82% | Dec 2024 |
|
| Northern Trust | 51k | $51k | 0% | Dec 2024 |
|
| Barclays | 50k | $27k | 0% | Dec 2024 |
|
| Susquehanna International | 49k | $26k | -78% | Dec 2024 |
|
| Palisades Investment Partners | 47k | $25k | 8% | Dec 2024 |
|
| Vontobel Holding | 43k | $23k | 0% | Dec 2024 |
|
| Graham Capital Management | 37k | $20k | 195% | Dec 2024 |
|
| Columbia Advisory Partners | 37k | $7.2k | 122% | Mar 2025 |
|
| Oppenheimer & Co | 32k | $17k | -12% | Dec 2024 |
|
| Raymond James Financial | 31k | $17k | 100% | Dec 2024 |
|
| CSS | 31k | $17k | 0% | Dec 2024 |
|
| Massey, Quick & Co | 30k | $5.9k | 0% | Mar 2025 |
|
| Millennium Management | 30k | $16k | -96% | Dec 2024 |
|
| Newman Dignan & Sheerar | 28k | $15k | 0% | Dec 2024 |
|
| Wealth Enhancement Advisory Services | 27k | $5.3k | 0% | Mar 2025 |
|
| Stifel Financial | 27k | $14k | -4% | Dec 2024 |
|
| Hsbc Holdings | 26k | $14k | 0% | Dec 2024 |
|
| Hunter Associates | 22k | $12k | -4% | Dec 2024 |
|
| Prosperity Wealth Management | 22k | $12k | -11% | Dec 2024 |
|
| Group One Trading | 21k | $11k | -58% | Dec 2024 |
|
| Tower Research Capital | 20k | $11k | 319% | Dec 2024 |
|
| Kingswood Wealth Advisors | 19k | $10k | 100% | Dec 2024 |
|
| Clear Harbor Asset Management | 19k | $10k | 100% | Dec 2024 |
|
| Rhumbline Advisers | 18k | $3.6k | -7% | Mar 2025 |
|
| Baader Bank | 18k | $8.7k | 100% | Dec 2024 |
|
| Squarepoint Ops | 17k | $8.9k | 100% | Dec 2024 |
|
| Goldman Sachs Group | 16k | $8.7k | -81% | Dec 2024 |
|
| Advisor Group Holdings | 15k | $15k | 0% | Dec 2024 |
|
| X-Square Capital | 11k | $6.3k | 0% | Dec 2024 |
|
| Global Retirement Partners | 6.0k | $3.2k | 0% | Dec 2024 |
|
| Lindbrook Capital | 4.6k | $2.5k | -5% | Dec 2024 |
|
| Atlantic Trust | 3.0k | $1.9k | 0% | Dec 2024 |
|
| IFP Advisors | 3.0k | $1.6k | 0% | Dec 2024 |
|
| Sandy Spring Bank | 1.1k | $565.950000 | 0% | Dec 2024 |
|
| Plante Moran Financial Advisors | 925.00 | $498.020000 | 0% | Dec 2024 |
|
| Federation des caisses Desjardins du Quebec | 755.00 | $407.020500 | 0% | Dec 2024 |
|
| Bryn Mawr Trust | 604.00 | $325.012400 | 0% | Dec 2024 |
|
| HighMark Wealth Management | 287.00 | $155.008700 | 0% | Dec 2024 |
|
| Parallel Advisors | 250.00 | $49.000000 | 0% | Mar 2025 |
|
| Bnp Paribas Arbitrage, Snc | 213.00 | $114.998700 | 0% | Dec 2024 |
|
| Transce3nd | 175.00 | $93.992500 | 100% | Dec 2024 |
|
| Investors Research Corp | 100.00 | $20.000000 | 0% | Mar 2025 |
|
| Farther Finance Advisors | 20.00 | $5.000000 | 100% | Mar 2025 |
|
| TD Waterhouse Canada | 14.00 | $7.999600 | 0% | Dec 2024 |
|
Who sold out of Adaptimmune Therapeutics?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| Matrix Capital Management Company | Sep 2024 | 38M | $36M |
| DAFNA Capital Management | Sep 2024 | 341k | $324k |
| GSA Capital Partners | Sep 2024 | 100k | $95k |
| Fullcircle Wealth | Sep 2024 | 35k | $26k |
| DLK Investment Management | Sep 2024 | 31k | $29k |
| Janney Montgomery Scott | Sep 2024 | 30k | $29k |
| IFG Advisory | Sep 2024 | 28k | $26k |
| Ballentine Partners | Sep 2024 | 17k | $16k |
| Commonwealth Equity Services | Sep 2024 | 13k | $13k |
| Quadrant Capital | Sep 2024 | 12k | $12k |
| Greenleaf Trust | Sep 2024 | 12k | $11k |
| Signature | Sep 2024 | 6.6k | $6.3k |
| Simplex Trading | Sep 2024 | 1.1k | $0 |
| Northwestern Mutual Wealth Management Company | Sep 2024 | 69.00 | $65.998500 |